Cite
MLA Citation
A. Guidetti et al.. “Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.” Leukemia research, vol. 62, n.d., pp. 91–97. http://access.bl.uk/ark:/81055/vdc_100053766847.0x000051